CATEGORIES

from super computing to health informatics

prof. rajat moona director general, c-dac spread across 11 centres in india, the centre for development of advanced computing, better known as c-dac, is working silently to usher in a healthcare revolution through ict. here’s an exclusive interview with c-dac’s director general, prof. rajat moona

Meeting of Minds of Senior Management on Both Sides Is Key to Merger Success

A study of the history of mergers and acquisitions offers a broad spectrum of lessons that should be learnt, so as to ensure that such deals are successful. Be it the first wave of consolidation that occurred in the US and Europe in the 1890s or the post globalisation conglomerate behemoths that are a result of the recent wave of mergers; a key component in the success of these operations is strategic human resources planning.

Digital Health​​​​​​​ the Dawn of a New Era in Healthcare

Technology has revolutionized almost all sectors, healthcare being no different. The convergence of technology and healthcare has opened up a whole new world of possibilities that promise to improve the quality and efficiency of various healthcare services. 

“Indian Customer Will Continue To See New Product Development”

SpectrumLabs.com is a global player in membrane separation technologies for the pharmaceutical, bioprocess, diagnostic and research industries. Spectrum focuses on two core technologies, Single-Use Hollow Fiber Tangential Flow Filtration and Tubular Membrane Dialysis.

India Needs Proper Biosupplier Ecosystem

With economic growth and addition of biotechnology to its portfolio, India is rapidly becoming a global player in the life sciences and healthcare space. Educating and achieving scientific excellence demands a really high level of R&D. Now that the government is investing more resources in research and medical facilities and infrastructure, from educational institutes to hospitals, use of lab equipment, reagents or medical devices are growing rapidly. This will drive the growth of biosupplier market in the country.

Biotech Parks Relevance & Untapped Potential

With effective regulatory framework, government and private support, biotechnology parks can provide an ideal platform for companies, universities and R&D institutes to promote bioactivities.

Demand For Specialised Infrastructure, Incubators Continues To Be Moderate To Strong

Utkarsh Palnitkar says only a few biotech parks support industry with ready-to-use lab facilities for R&D, incubation support for start-ups and dedicated land for scaling up activities are operational in India.

The Nano Approach Of Medicines

Increase in adoption of novel nanomedicines products drives the market growth in India. Moreover, increase in the number of players and high adoption of innovative technologies further fuel the market growth. In addition, robust government initiative toward improvement of healthcare facilities through insurance schemes is anticipated to provide lucrative growth opportunities in the country. The nanomedicines market in India is expected to grow at the highest CAGR of 13.4% from 2016 to 2023.

High Growth Health Insurance Market Still Remains Underpenetrated

India’s healthcare industry is one of the fastest growing sectors and in the coming 10 years it is expected to reach $275 billion. Indian healthcare sector is much diversified and is full of opportunities in every segment which includes providers, payers and medical technology. With the increase in the competition, businesses are looking to explore for the latest dynamics and trends which will have positive impact on their business.

India Gets Its First Oncology Tutorial Series

The Union Health Ministry has launched a digital Online Oncology Tutorial Series, which is part of a national programme that will be rolled out across the country in collaboration with state governments.

“Data Sharing, Post Study Access To Trial Medication Are Emerging Frontiers”

“Data Sharing and Post study access to trial medication for study subjects are the two emerging frontiers in clinical research space,” said Dr Saral Thangam, CEO & Managing Director, Norwich Clinical Services.

Biotechnology - Where Is It Heading?

On one hand, the biotechnology industry is starved of skilled talent pool. On the other hand, there are several universities and colleges, producing number of unemployable graduates. While some of them are struggling due to lack of students. So serious thinking needs to be done urgently to overcome this problem.

Pharma Exporters To US Under Pressure

Recent USFDA hike of fee for processing ANDA will certainly going to put immense pressure on the Indian pharma industry, resulting eviction of many small players from this pharma export business.

“We Have Streamlined The Whole Process Of Reviewing And Approval”

Indian Council of Medical Research (ICMR) signed an agreement recently with other global agencies to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly available registry. 

India Free From Avian Influenza

Strict surveillance including culling, disinfection and clean-up have worked remarkably in making India free from Avian Influenza. Specified actions formulated by the Ministry of Health still needs to be taken up regularly.

Growing Burden Of Head And Neck Cancer In India

Despite great advancements, the management of Head and Neck cancers still remains a problematic and intriguing issue due to the complex anatomy of the various sites.

Industry - Academia Collaboration For The Early Development Of Biopharmaceuticals

With an aim of creating a globally competitive biopharmaceutical industry that addresses the country’s major concerns around barriers to affordable healthcare, Innovate in India (I3) program was launched by Dr Harsh Vardhan, Union Minister of Science & Technology on 30th June 2017 in New Delhi.

PE Giants Eyeing Stake At Mankind Worth Crores

Big private equity firms and sovereign wealth funds are exploring a purchase deal share worth at least Rs 5,000-crore ($750-million) in India’s fifth largest drug maker Mankind Pharma.

Promoting Affordable Healthcare

WITH MORE THAN 25 YEARS OF EXPERIENCE IN HEALTHCARE, TERRI BRESENHAM HAS MADE SEVERAL CONTRIBUTIONS TOWARDS ADDRESSING GLOBAL HEALTH ISSUES

Assisting Breast Cancer Diagnosis

AFTER LEADING THE CANCER DRUG DISCOVERY AND MULTI-DISCIPLINARY RESEARCH ON ‘POINT-OF-CARE’ DIAGNOSTICS AT RENOWNED COMPANIES, DR MANJIRI M. BAKRE IS NOW DEVELOPING COST EFFECTIVE AND RELIABLE TESTS FOR PERSONALIZED CANCER TREATMENT.

Transforming Hair & Skin Care

A DOCTORATE IN TRICHOLOGY HELPED DR BANI ANAND TO TAKE HAIR & SKIN CARE TREATMENT FROM NON-SURGICAL COMPETENCIES TO SURGICAL TREATMENT OPTIONS.

Enhancing Clinical Drug Developments

WITH HER 20 YEARS OF EXPERIENCE, BINDHYA CARIAPPA IS WORKING ON PUTTING INDIA ON THE GLOBAL CLINICAL TRIAL MAP.

Agilent In Agreement With Agendia For Cancer Diagnostics

Agilent Technologies Inc. and Agendia, Inc. have jointly announced an agreement to expand their relationship to include the development of an RNA Seq kit version of Agendia’s currently marketed Mamma Print and Blueprint tests.

Nanoparticles For Treating Eye Infections

Scientists at the Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) have developed a novel way to treat fungal keratitis.

Global Pharma Continues To See Potential In Investing In R&D In India

Innovative biopharmaceutical companies around the world continue to strive to accelerate the pace of innovation and deliver effective medicines to patients quickly and efficiently. By investing more time, energy, and resources in collaboration across the R&D ecosystem and leveraging more sophisticated research and manufacturing tools, these companies in India continue to invest in R&D and advance the science forward.

Competition Is Getting Fierce Among The 'Health Startups' In India

Medical care is just a click away but this has also blown a trumpet of online combat between these startups. Currently, it may look like a wide field to play in but in the coming years, there will be more players joining these online battle and then it will become a cut throat competition

GST To Have Constructive Effect On The Pharma And Healthcare Sectors

Though healthcare and pharma sectors hailed the announcement of GST rates, by saying that GST will encourage local manufacturing sector to step into producing products that will be more affordable for the local consumers. But with introduction of GST ayurvedic medicines will be taxed at 12 per cent from the current tax rate of 7 per cent, which has disappointed the Ayurvedic medicines industry badly.

There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients

There Is Need To Increase Awareness About Clinical Research That Has Done Good For Patients

The New Challenges Demand That We Make Innovative Strategies: J P Nadda

The New Challenges Demand That We Make Innovative Strategies: J P Nadda

Thermo Fisher Scientific India Conducts Genetic Solutions World Tour

As part of the Genetics Solutions World Tour, Thermo Fisher India recently organized seminars in Delhi & Bengaluru to showcase our market leadership and establish new opportunities for Sanger sequencing, Next Generation Sequencing (NGS) and Microarray.